Amidst of COVID-19 outbreak, Infinium wishes to extend its support to the industry by offering 30% discount on its market research reports across all license formats.

Human Microbiome Market (Product - Probiotics, Prebiotics, Medical Foods, Supplements, and Other Products; Application - Therapeutics, and Diagnostics; Disease Type - Obesity, Diabetes, Autoimmune Disorder, Acute Diarrhea, Metabolic & Gastrointestinal Disorders, Cancer, and Other Diseases): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : August, 2019

  • Rep Id : HC0626

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on human microbiome market provides an in-depth analysis of segments and sub-segments in the global as well as regional human microbiome market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional human microbiome market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global human microbiome market. According to the report, the global human microbiome market is projected to grow at a CAGR of 21.3% over the forecast period of 2019-2025.

Market Insight

The growing occurrence of diseases such as diabetes, cancer, and obesity are the major factors that drive the growth of the global human microbiome market across the globe. According to an article published by the National Center for Biotechnology Information, nearly 285 million people were affected by diabetes across the world in 2010 and the number is expected to reach 439 million by 2030.  The rising number of the aging population is one of the other key factors that help in the growth of the market. Furthermore, the presence of several research centers that are paying immense attention to the study of human microbiomes also fuels the growth of the market. Besides, growing awareness among people about the advantages of microbiome products also boosts the growth of the human microbiome market. However, stringent government regulations may restrain the growth of the market. Moreover, advancement in biomedical science creates an opportunity for the growth of the global human microbiome market in the next few years.

In terms of region, the global human microbiome market is segmented into North America, Europe, Asia Pacific and Rest of the World.  Among all, North America is leading the market and is estimated to dominate the market during the forecast period. This is attributed to the rising incidences of lifestyle diseases and autoimmune disorders. The United States holds the largest market share for the human microbiome followed by Canada in North America. Europe is the second most dominating region in the global human microbiome market due to improved microbiological and biotechnological research infrastructure. However, Asia Pacific is estimated to grow at a faster rate in the global human microbiome market over the forecast period. This is accredited to improving research infrastructure in the region. Furthermore, several government associations are also boosting the growth of the human microbiome market in the region by providing funds to increase research in the field of life science. India and China are estimated to be the fastest-growing human microbiome market in the Asia Pacific region.

Global Human Microbiome Market

Segment Covered

The report on the global human microbiome market covers segments such as product, application, and disease type. On the basis of product, the sub-markets include probiotics, prebiotics, medical foods, supplements, and other products. On the basis of application, the sub-markets include therapeutics, and diagnostics. On the basis of disease type, the sub-markets include obesity, diabetes, autoimmune disorder, acute diarrhea, metabolic & gastrointestinal disorders, cancer, and other diseases. 

Companies Profiled:

The report provides profiles of the companies in the market such as Enterome Bioscience, Merck, Yakult, DuPont, ViThera Pharmaceuticals, MicroBiome Therapeutics LLC, Second Genome Inc., Vedanta BioSciences, Osel Inc., Metabiomics Corporation, and Other Companies. 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of human microbiome market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount